Why the study?
Does vitronectin blockade prevent neointima formation and smooth muscle cell migration after vascular injury?
Population
Sprague-Dawley rats undergoing balloon carotid injury and human smooth muscle cells in vitro
Design
Preclinical
Follow-up
7 days
Authors
Loading...
May support vitronectin blockade to limit neointimal hyperplasia; leaves open translation to human restenosis prevention.
Does vitronectin blockade prevent neointima formation and smooth muscle cell migration after vascular injury?
Vitronectin blockade reduces neointima formation and smooth muscle cell migration following vascular injury, highlighting a potential therapeutic target for preventing restenosis.
Pascale Dufourcq (2002) studied this question.